CymitQuimica logo

CAS 131926-98-2

:

5-HYDROXY LANSOPRAZOLE

Description:
5-Hydroxy Lansoprazole is a derivative of Lansoprazole, which is a proton pump inhibitor (PPI) commonly used to treat conditions like gastroesophageal reflux disease (GERD) and peptic ulcers. This compound is characterized by the presence of a hydroxyl group at the fifth position of the Lansoprazole structure, which may influence its pharmacological properties and metabolic stability. It typically appears as a white to off-white solid and is soluble in organic solvents. The molecular formula reflects its complex structure, which includes a benzimidazole ring, a pyridine ring, and a sulfinyl group. The compound's mechanism of action involves the inhibition of the H+/K+ ATPase enzyme in the gastric parietal cells, leading to decreased gastric acid secretion. As a metabolite of Lansoprazole, 5-Hydroxy Lansoprazole may play a role in the drug's overall efficacy and safety profile, although its specific pharmacokinetics and dynamics can vary. Understanding its characteristics is essential for evaluating its therapeutic potential and interactions within the body.
Formula:C16H14F3N3O3S
Synonyms:
  • 2-[[[3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]-1H-benzimidazol-5-ol
  • 5-Hydroxy Lansoprazole >90%
  • 2-[3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridylmethylsulfinyl]-5-hydroxy-1H-benzimidazole
  • 2-[[3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methylsulfinyl]-1H-benzimidazole-5-ol
  • AG-1908
  • 5-HYDROXY LANSOPRAZOLE
  • Lansoprazole 5-Hydroxy Impurity
  • DISCONTINUED. See H943711
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 3 products.